InsidersTradesSigma
Total declarations
Company
▲ Purchases (3 ops.)
▼ Sales (0 ops.)
Explore the detailed record of transactions filed by Patel Mahesh V., Chairman & CEO. Director active across 1 companies, notably Lipocine Inc.. In total, 3 disclosures have been published. Total volume traded: €85k. The latest transaction was filed on 16 May 2022 — Acquisition. Regulator: SEC (Form 4). The full history is accessible without signup.
Declarations3 total
€36,87650,000 shares@ €0.73750.20% mcap43.4% of flow
Common Stock
SEC:0001493152-22-014014:0·
Ideal exit: 10 Feb 2023 (T+270)
€24,07025,000 shares@ €0.9628100.0% of flow
Common Stock
SEC:0001493152-21-029268·
Ideal exit: 15 Aug 2022 (T+270)
€24,07025,000 shares@ €0.96280.13% mcap28.3% of flow
Common Stock
SEC:0001493152-21-029268:0·
Ideal exit: 15 Aug 2022 (T+270)
3 of 3 declarations
About Patel Mahesh V.
Mahesh V. Patel is the CEO and President of Lipocine Inc. He leads the company focused on developing innovative pharmaceutical treatments. His role is essential in guiding the strategy and ensuring the growth of Lipocine.
